Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

To evaluate the long-term outcomes of ranibizumab (RBZ) vs. aflibercept (AFL) in treatment-naïve eyes with typical neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV). This multicenter, retrospective, matched-cohort analysis was conducted on data  up to 4 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ki Won, Kim, Jae Hui, Park, Jun Young, Park, Sang Jun, Park, Kyu Hyung, Lee, Joo Yong, Woo, Se Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285484/
https://www.ncbi.nlm.nih.gov/pubmed/34272419
http://dx.doi.org/10.1038/s41598-021-93899-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285484/
https://www.ncbi.nlm.nih.gov/pubmed/34272419
http://dx.doi.org/10.1038/s41598-021-93899-x

Ejemplares similares